JP2021531288A5 - - Google Patents

Info

Publication number
JP2021531288A5
JP2021531288A5 JP2021502879A JP2021502879A JP2021531288A5 JP 2021531288 A5 JP2021531288 A5 JP 2021531288A5 JP 2021502879 A JP2021502879 A JP 2021502879A JP 2021502879 A JP2021502879 A JP 2021502879A JP 2021531288 A5 JP2021531288 A5 JP 2021531288A5
Authority
JP
Japan
Prior art keywords
stem cells
pharmaceutical composition
mitochondrial
human
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021502879A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021531288A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2019/050822 external-priority patent/WO2020021535A1/en
Publication of JP2021531288A publication Critical patent/JP2021531288A/ja
Publication of JP2021531288A5 publication Critical patent/JP2021531288A5/ja
Pending legal-status Critical Current

Links

JP2021502879A 2018-07-22 2019-07-22 眼疾患のミトコンドリア増強療法 Pending JP2021531288A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862701783P 2018-07-22 2018-07-22
US62/701,783 2018-07-22
US201862753943P 2018-11-01 2018-11-01
US62/753,943 2018-11-01
PCT/IL2019/050822 WO2020021535A1 (en) 2018-07-22 2019-07-22 Mitochondrial augmentation therapy of ocular diseases

Publications (2)

Publication Number Publication Date
JP2021531288A JP2021531288A (ja) 2021-11-18
JP2021531288A5 true JP2021531288A5 (cg-RX-API-DMAC7.html) 2022-07-13

Family

ID=69181375

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021502879A Pending JP2021531288A (ja) 2018-07-22 2019-07-22 眼疾患のミトコンドリア増強療法

Country Status (4)

Country Link
US (1) US12239672B2 (cg-RX-API-DMAC7.html)
EP (1) EP3823641A4 (cg-RX-API-DMAC7.html)
JP (1) JP2021531288A (cg-RX-API-DMAC7.html)
WO (1) WO2020021535A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL282198B2 (en) 2011-09-11 2025-11-01 Minovia Therapeutics Ltd Compositions of functional mitochondria and uses thereof
US12502408B2 (en) 2018-07-22 2025-12-23 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy for primary mitochondrial diseases
US12329781B2 (en) 2018-07-22 2025-06-17 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy of renal diseases
EP3823644A4 (en) 2018-07-22 2022-06-08 Minovia Therapeutics Ltd. MITOCHONDRIAL AUGMENTATION THERAPY OF PANCREATIC DISEASES
JP7524157B2 (ja) 2018-07-22 2024-07-29 ミノヴィア セラピューティクス リミテッド 脳疾患のミトコンドリア増強療法
WO2020021539A1 (en) 2018-07-22 2020-01-30 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy of muscle diseases
WO2020021535A1 (en) 2018-07-22 2020-01-30 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy of ocular diseases
KR20210045435A (ko) * 2018-08-14 2021-04-26 이멜 바이오테라퓨틱스, 인코포레이티드. 미토콘드리아 질환 또는 장애 및 헤테로플라스미를 치료하기 위한 방법 및 조성물
US12478644B2 (en) 2019-04-03 2025-11-25 Mor Research Applications Ltd. Mitochondrial transplantation and use thereof in ocular diseases
US12508282B2 (en) 2019-04-03 2025-12-30 Mor Research Applications Ltd. Mitochondrial transplantation and use thereof in ocular diseases
JP7745544B2 (ja) 2019-10-24 2025-09-29 イメル バイオセラピューティクス,インク. ミトコンドリアdna中のマクロヘテロプラスミー及びミクロヘテロプラスミーを検出するための方法
MX2022012157A (es) 2020-03-31 2023-02-15 Minovia Therapeutics Ltd Celulas geneticamente modificadas enriquecidas con mitocondrias y usos de estas.
TWI759739B (zh) * 2020-05-08 2022-04-01 台灣粒線體應用技術股份有限公司 新穎性醫藥組合物於修復視網膜損傷與治療視網膜病變之用途

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9604400A (es) 1994-03-30 1997-12-31 Mitokor Diagnostico, terapia y modelos celular y animal para enfermedades asociadas con defectos mitocondriales.
US6472378B2 (en) 1998-08-31 2002-10-29 Pro-Neuron, Inc. Compositions and methods for treatment of mitochondrial diseases
JP2002538167A (ja) 1999-03-03 2002-11-12 バイオジェン インコーポレイテッド 脂質の代謝および貯蔵を調節する方法
GB2350565A (en) 1999-05-28 2000-12-06 Johnson & Johnson Medical Ltd Biological wound dressings comprising mitochondria
DE19937348A1 (de) 1999-08-11 2001-02-22 Aventis Cropscience Gmbh Nukleinsäuremoleküle aus Pflanzen codierend Enzyme, die an der Stärkesynthese beteiligt sind
JP2004500409A (ja) 2000-03-31 2004-01-08 ザ ジェネラル ホスピタル コーポレーション 毛の成長を調節する方法
EP1325743A4 (en) 2000-10-13 2004-12-15 Chugai Pharmaceutical Co Ltd COMPOSITIONS TO IMPROVE FAT METABOLISM
US20030040475A1 (en) 2001-01-16 2003-02-27 Yasuhiro Toba Agents for improving lipid metabolism and reducing high blood pressure
US7339090B2 (en) 2001-02-13 2008-03-04 Avigenics, Inc. Microinjection devices and methods of use
JP4603192B2 (ja) 2001-05-10 2010-12-22 株式会社カネカ 毛髪頭皮用組成物
WO2003012050A2 (en) 2001-07-31 2003-02-13 Northeastern University Mitochondrial genome replenishment
AU2002324645C1 (en) 2001-08-08 2008-11-06 Levesque Biosciences, Inc. Compositions and methods for isolation, propagation, and differentiation of human stem cells and uses thereof
US7138134B2 (en) 2001-12-18 2006-11-21 Arizona Health Consulting Group, Llc Preparation and administration of jojoba product for reducing weight, fat and blood lipid levels
US20050153381A1 (en) 2002-02-14 2005-07-14 Marusich Michael F. Immunocapture of mitochondrial protein complexes
AU2004238375A1 (en) 2003-05-13 2004-11-25 The Regents Of The University Of Colorado Diagnostic and therapeutic treatments related to mitochondrial disorders
WO2004103389A2 (en) 2003-05-22 2004-12-02 Theraptosis Sa Means for preventing and treating cellular death and their biological applications
US7407800B1 (en) 2003-09-19 2008-08-05 Pierce Biotechnology, Inc. Method for the isolation of intact mitochondria from cells
CA2551190A1 (en) 2003-12-23 2005-07-07 Nono Inc. Polypeptides for modulating binding of trp channel proteins and trp-associated proteins.
US20060024277A1 (en) 2004-07-27 2006-02-02 Sivak Hannah N Method of skin care and/or treatment using extracts enriched in mitochondria
JP2006131600A (ja) 2004-11-09 2006-05-25 R & D Cell-Science Optional Medico:Kk 発毛促進のためのヒト細胞組成物
EP3417868A1 (en) 2005-06-10 2018-12-26 Thylabisco AB Composition
AU2012201710B2 (en) 2006-05-11 2014-01-16 Regenics As Administration of cells and cellular extracts for rejuvenation
AT502353B1 (de) 2006-06-29 2007-07-15 Avl List Gmbh Verfahren und vorrichtung zur konditionierung eines o2-hältigen gases
CA2688125A1 (en) 2007-05-02 2008-11-13 The Mclean Hospital Corporation Methods and compositions for mitochondrial replacement therapy
WO2008152640A2 (en) 2007-06-13 2008-12-18 Pluristem Ltd. Three dimensional biocompatible scaffolds for ex-vivo expansion and transplantation of stem cells
WO2009154770A2 (en) 2008-06-18 2009-12-23 The Texas A & M University System Mesenchymal stem cells, compositions, and methods for treatment of cardiac tissue damage
US20110105359A1 (en) 2009-10-30 2011-05-05 Xenotech, Llc Cryopreservation of cells and subcellular fractions
US8338178B2 (en) 2010-10-28 2012-12-25 The Invention Science Fund I, Llc Mitochondrial enhancement of cells
DK2645993T3 (en) 2010-12-03 2017-02-13 Allergan Inc Pharmaceutical cream compositions comprising oxymetazoline
CN113142581B (zh) 2010-12-23 2025-07-22 阿马曾提斯公司 用于改善线粒体功能的组合物和方法
EP2726601B1 (en) 2011-06-29 2018-12-26 The General Hospital Corporation Compositions and methods for enhancing bioenergetic status in female germ cells
CN102266350A (zh) 2011-07-20 2011-12-07 黄必录 逆转干细胞衰老的方案
US20130022666A1 (en) 2011-07-20 2013-01-24 Anna Brzezinska Methods and compositions for transfer of mitochondria into mammalian cells
CN102293178A (zh) 2011-08-28 2011-12-28 黄必录 使个体去衰老的方法
IL282198B2 (en) 2011-09-11 2025-11-01 Minovia Therapeutics Ltd Compositions of functional mitochondria and uses thereof
CN104066837B (zh) 2011-12-02 2020-12-08 菲特治疗公司 增强的干细胞组合物
US8648034B2 (en) 2011-12-09 2014-02-11 Changhua Christian Hospital Method and applications of peptide-mediated mitochondrial delivery system
WO2013149064A1 (en) 2012-03-30 2013-10-03 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Uridine diphosphate compounds as mobilizers of hematopoietic progenitor cells
US10702556B2 (en) 2012-05-16 2020-07-07 Minovia Therpautices Ltd. Compositions and methods for inducing angiogenesis
WO2014091312A2 (en) 2012-12-10 2014-06-19 Regenics As Use of cellular extracts for skin rejuvenation
ES2860573T3 (es) 2013-02-19 2021-10-05 Childrens Medical Center Células madre ABCB5(+) para el tratamiento de enfermedades oculares
DE102013225588A1 (de) 2013-12-11 2014-04-17 Henkel Ag & Co. Kgaa Verwendung und Mittel zur Verbesserung der Haarstruktur
KR20240164967A (ko) 2014-02-04 2024-11-21 카이트 파마 인코포레이티드 B 세포 악성종양 및 다른 암을 치료하는데 유용한 자가 t 세포 및 그의 조성물의 생산 방법
EP2918458B1 (en) 2014-03-11 2016-12-07 Autoliv Development AB A vehicle braking arrangement
US20170080030A1 (en) 2014-03-17 2017-03-23 University Of Virginia Patent Foundation Compositions and methods for treating retinopathy
CN103976935A (zh) 2014-05-28 2014-08-13 广州市白云区天芳化妆品厂 一种抗衰原液及其制备方法
US10738278B2 (en) 2014-07-15 2020-08-11 Juno Therapeutics, Inc. Engineered cells for adoptive cell therapy
WO2016008937A1 (en) 2014-07-16 2016-01-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the intercellular transfer of isolated mitochondria in recipient cells
WO2016037587A1 (en) 2014-09-11 2016-03-17 Taiwan Mitochondrion Applied Technology Co., Ltd Pharmaceutical compositions for treating degenerative neurological disease with mitocells
JP6441472B2 (ja) 2014-09-30 2018-12-19 台灣粒線體應用技術股▲扮▼有限公司Taiwan Mitochondrion Applied Technology Co.,Ltd. 活性成分として外因性ミトコンドリアを含む組成物、ならびにその使用およびそのための細胞修復法
EP3219322A4 (en) 2014-11-14 2018-06-20 JCR Pharmaceuticals CO., LTD. Muscular dystrophy therapeutic agent containing pluripotent stem cells derived from dental pulp
GB201500427D0 (en) 2015-01-12 2015-02-25 Isis Innovation Method
WO2016112425A1 (en) 2015-01-14 2016-07-21 Calix Ltd Improved pathogen inhibitor
US20180030413A1 (en) 2015-02-26 2018-02-01 Minovia Therapeutics Ltd. Mammalian cells enriched with functional mitochondria
US10537594B2 (en) 2015-02-27 2020-01-21 University Of Connecticut Targeted transplantation of mitochondria to hepatocytes
KR20180019613A (ko) 2015-05-28 2018-02-26 셀룰래리티, 인코포레이티드 태반-유래 줄기 세포 및 그의 재생 엔진 복구, 프로테옴 결함 수정 및 노화 객체의 수명 연장 용도
US20170151287A1 (en) 2015-11-30 2017-06-01 Flagship Ventures Management, Inc. Methods and compositions of chondrisomes
ES3057779T3 (en) 2016-01-15 2026-03-04 Childrens Medical Ct Corp Therapeutic use of mitochondria and combined mitochondrial agents
AU2017354272A1 (en) 2016-11-03 2019-05-23 Exostem Biotec Ltd. Mesenchymal stem cells populations, their products, and use thereof
WO2018088874A1 (ko) * 2016-11-14 2018-05-17 주식회사 파이안바이오테크놀로지 외래 미토콘드리아를 세포로 전달하는 방법
CN110022884A (zh) 2016-11-30 2019-07-16 白雁生物技术公司 含有线粒体的药物组合物
US20200023005A1 (en) 2017-03-26 2020-01-23 Minovia Therapeutics Ltd. Mitochondrial compositions and methods for treatment of skin and hair
WO2020021541A1 (en) 2018-07-22 2020-01-30 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy with stem cells enriched with functional mitochondria
US12502408B2 (en) 2018-07-22 2025-12-23 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy for primary mitochondrial diseases
EP3823644A4 (en) 2018-07-22 2022-06-08 Minovia Therapeutics Ltd. MITOCHONDRIAL AUGMENTATION THERAPY OF PANCREATIC DISEASES
WO2020021537A1 (en) 2018-07-22 2020-01-30 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy of liver diseases
JP7524157B2 (ja) 2018-07-22 2024-07-29 ミノヴィア セラピューティクス リミテッド 脳疾患のミトコンドリア増強療法
WO2020021535A1 (en) 2018-07-22 2020-01-30 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy of ocular diseases
WO2020021539A1 (en) 2018-07-22 2020-01-30 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy of muscle diseases
KR20210045435A (ko) 2018-08-14 2021-04-26 이멜 바이오테라퓨틱스, 인코포레이티드. 미토콘드리아 질환 또는 장애 및 헤테로플라스미를 치료하기 위한 방법 및 조성물
CA3138566A1 (en) 2019-04-30 2020-11-05 Larimar Therapeutics, Inc. Frataxin-sensitive markers for determining effectiveness of frataxin replacement therapy
CN115427052A (zh) 2020-03-31 2022-12-02 米诺维亚治疗公司 线粒体加强疗法
MX2022012157A (es) 2020-03-31 2023-02-15 Minovia Therapeutics Ltd Celulas geneticamente modificadas enriquecidas con mitocondrias y usos de estas.

Similar Documents

Publication Publication Date Title
JP5649786B2 (ja) ヒト胚性幹細胞およびそれらの誘導体を含む組成物、使用方法、ならびに調製方法
Abnave et al. Role of the immune system in regeneration and its dynamic interplay with adult stem cells
JP2021532094A5 (cg-RX-API-DMAC7.html)
JP2021532091A5 (cg-RX-API-DMAC7.html)
JP2021532093A5 (cg-RX-API-DMAC7.html)
JP2021532095A5 (cg-RX-API-DMAC7.html)
JPH11147829A (ja) 疼痛を軽減し行動異常および知覚異常を治療するための 筋芽細胞導入療法
JP6267713B2 (ja) 網膜変性処置のための方法および組成物
JP2021531288A (ja) 眼疾患のミトコンドリア増強療法
RU2005105065A (ru) Стволовые кроветворные клетки и способы лечения с их помощью глазных болезней, связанных с новообразованием сосудов
Bao et al. Transplantation of Human umbilical cord mesenchymal stem cells promotes functional recovery after spinal cord injury by blocking the expression of IL-7.
US20170204151A1 (en) Mesenchymal Stem Cells Expressing Biomarkers that Predict the Effectiveness of Mesenchymal Stem Cells for Treating Diseases and Disorders
US11753623B2 (en) Compositions for treating retinal diseases and methods for making and using them
Chen et al. Abdominal aortic transplantation of bone marrow mesenchymal stem cells regulates the expression of ciliary neurotrophic factor and inflammatory cytokines in a rat model of spinal cord ischemia-reperfusion injury
US20200246380A1 (en) Pharmaceutical Composition for Preventing or Treating Autoimmune Disease, and Method for Producing Same
KR20160109019A (ko) 지방-유래 줄기세포를 함유하는 정맥혈관 투여를 통한 아토피 피부염의 예방 또는 치료용 조성물
JP2021531281A5 (cg-RX-API-DMAC7.html)
JP2016008198A (ja) 間質性膀胱炎の治療
CN114191444B (zh) Lc-a在制备治疗和预防增殖性糖尿病性视网膜病变药物中的应用
CN110016083A (zh) 一种fgf-1融合蛋白及其在脊髓损伤治疗中的用途
KR20250042183A (ko) IFN-γ에 선택적으로 결합하는 DNA 올리고뉴클레오티드를 함유한 드라이 아이 치료제
CN115737781A (zh) 枸杞糖肽新用途及药物
TWI759739B (zh) 新穎性醫藥組合物於修復視網膜損傷與治療視網膜病變之用途
Florido et al. Mesenchymal stem cells for treatment of retinitis pigmentosa: short review
CA3230019A1 (en) Fusion protein of interleukin-2 and application thereof in als